GlassScriptPhysician profile
Sahas Narain
NPI 1346773041
$6,257.78
in general payments reported to CMS, 2019-2025
17 companies · $3,911 in 2025
The $3,911 reported for 2025 was more than what 91% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2023: $367 · 2024: $1,853 · 2025: $3,911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,856 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,855.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,275.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,709.08 | 2021-2025 | Clareon Panoptix Pro, Clareon, Simbrinza |
| Bausch & Lomb Americas INC. | $1,378.77 | 2023-2025 | Envista Mx60 Iol, Envista Aspire Iol, Miebo |
| Tarsus Pharmaceuticals, INC. | $728.89 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $443.54 | 2025 | |
| Rxsight INC | $178.76 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Dompe US, INC. | $161.64 | 2024-2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $102.47 | 2024-2025 | Acthar |
| Harrow Eye, LLC | $100.14 | 2024-2025 | Vevye |
| Ani Pharmaceuticals, INC. | $94.14 | 2024-2025 | Purified Cortrophin Gel |
| Biotissue Holdings INC. | $74.42 | 2024-2025 | |
| Sight Sciences, INC. | $61.48 | 2021-2023 | Omni Surgical System |
| Oyster Point Pharma, INC. | $60.60 | 2023-2025 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $49.35 | 2025 | Veritas Vision System |
| Amgen INC. | $44.12 | 2024 | Tepezza |
| Ivantis, INC | $29.51 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $26.87 | 2024 | |
| Rayner Intraocular Lenses Limited | $14.00 | 2025 | Rayner Cataract Set 1, Rayone Spheric, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sahas Narain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.